IFF vs SYIEY: Which Is the Better Buy in 2026?

Last updated October 2026

Short answer

IFF is the larger of the two ($21.27B market cap): the incumbent the market prices for continued execution (21.03x forward earnings, beta 0.95). SYIEY is the smaller challenger ($14.17B), cheaper on forward earnings (5.18x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

IFF vs SYIEY: the tie-breaker metrics

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Metric	IFF	SYIEY	What it tells you
Market cap	$21.27B	$14.17B	Size. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E	21.03	5.18	Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta	0.95	0.57	Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range	80% of range	81% of range	Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book	1.52	3.37	How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: SYIEY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how IFF and SYIEY affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IFF and SYIEY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IFF and SYIEY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does International Flavors & Fragrances Inc. (IFF) do?

International Flavors & Fragrances makes the taste, scent and functional ingredients that go into other companies' products: flavor systems for beverages, snacks and dairy, fine and consumer fragrances, enzymes, cultures, probiotics and soy proteins. The company traces to 1833 and reached its current scale through the 2018 Frutarom acquisition and the February 2021 Reverse Morris Trust merger with DuPont's Nutrition & Biosciences division, a roughly $26 billion combination that made IFF one of the four global ingredient houses alongside Givaudan, dsm-firmenich and Symrise. As of the second quarter of 2026 it reports three continuing segments, Taste (~$688 million of quarterly sales), Health & Biosciences (~$601 million) and Scent (~$665 million), after moving the Food Ingredients and Soy Crush businesses into discontinued operations.

Full IFF guide

What does Symrise AG (SYIEY) do?

Symrise AG develops and makes flavors, fragrances and functional ingredients that other companies put into their own products: the taste in a soft drink or snack, the scent in a shampoo or fine perfume, the palatability coating that makes dry pet food appealing to cats and dogs, and active ingredients such as UV filters and preservatives for cosmetics. It sells to food, beverage, pet-food, personal-care and household-goods manufacturers worldwide and earns money on volume of ingredients sold, usually under long-running supply relationships where a flavor or scent is written into a customer's formula. In 2025 Symrise reported sales of ~€4.93 billion, up 2.8% organically, with foreign exchange and portfolio changes taking about €210 million off the reported figure.

Full SYIEY guide

IFF vs SYIEY: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

IFF drivers: The Food Ingredients sale and the capital return attached to it; Deleveraging from the DuPont merger is essentially complete.
SYIEY drivers: Organic growth recovering from a weak first quarter; Margins and the ONE SYM transformation.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The CVC transaction is not expected to close until the end of the second quarter of 2027 and remains subject to regulatory approvals, so both the $2.0 billion post-close buyback and the promised debt paydown are contingent rather than banked. For SYIEY, the largest risk is growth falling short of plan.

IFF or SYIEY: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick IFF if you believe its drivers more; SYIEY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IFF and SYIEY guides.

IFF vs SYIEY: the full fundamentals

IFF. The two revenue figures are not a contradiction: trailing revenue of ~$10.8 billion covers the whole company, while 2026 guidance of ~$7.4 billion to ~$7.6 billion covers only the three segments IFF is keeping, since Food Ingredients and the Soy Crush businesses moved to discontinued operations in the second quarter. Trailing GAAP EPS of ~$1.08 puts the shares near 78 times earnings, a number distorted by amortization and disposal charges, which is why the forward multiple of roughly 25 times is the one most analysts quote. Enterprise value of about $26.6 billion against ~$2.06 billion of trailing credit adjusted EBITDA works out near 13 times, while Food Ingredients is being sold at roughly 8 times its own EBITDA.

SYIEY. At the €92.24 Frankfurt share price shown on Symrise's investor page in October 2026, the stock trades at roughly 25 times 2025 adjusted EPS. That is a premium multiple for a company growing low single digits, and it reflects the predictability of flavor and fragrance demand plus margins near 22%. The gap between adjusted EPS (€3.67) and IFRS EPS (€1.78) comes mostly from the Q4 2025 impairments on terpenes and Swedencare, which were non-cash. The €1.25 dividend equals a yield of about 1.4% at that price, before German withholding. Because four SYIEY ADRs equal one share, each ADR represents about a quarter of the per-share figures above, converted to dollars.

Headline figures (approximate, August 2026): IFF shows revenue (ttm, all businesses) ~$10.8B, fy 2026 sales guidance (continuing operations) ~$7.4B to ~$7.6B, q2 2026 adjusted operating ebitda margin ~20.9%, adjusted eps ex-amortization (first half 2026) ~$1.74; SYIEY shows revenue (fy2025) ~€4.93B (+2.8% organic), revenue (h1 2026) ~€2.54B (+2.0% organic), adjusted ebitda margin (h1 2026) ~21.8%, adjusted eps (fy2025) €3.67 (IFRS €1.78).

The bottom line: IFF vs SYIEY

IFF and SYIEY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IFF and SYIEY exposure against your real portfolio. It is not an investment adviser.

Wondering how IFF or SYIEY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in International Flavors & Fragrances Inc. with AI

Connect the broker you already use and ask Walnut's AI how IFF fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

Does IFF fit me?

FAQ

What is the difference between IFF and SYIEY?

International Flavors & Fragrances makes the taste, scent and functional ingredients that go into other companies' products: flavor systems for beverages, snacks and dairy, fine and consumer fragrances, enzymes, cultures, probiotics and soy proteins. Symrise AG develops and makes flavors, fragrances and functional ingredients that other companies put into their own products: the taste in a soft drink or snack, the scent in a shampoo or fine perfume, the palatability coating that makes dry pet food appealing to cats and dogs, and active ingredients such as UV filters and preservatives for cosmetics. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is IFF or SYIEY the better stock?

Neither is universally better. IFF is the larger incumbent; SYIEY is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, IFF or SYIEY?

On forward P/E (as of October 2026), IFF trades at 21.03x and SYIEY at 5.18x, so SYIEY is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both IFF and SYIEY?

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of IFF vs SYIEY?

IFF: The CVC transaction is not expected to close until the end of the second quarter of 2027 and remains subject to regulatory approvals, so both the $2.0 billion post-close buyback and the promised debt paydown are contingent rather than banked. Stranded costs are the near-term execution problem: roughly $3.2 billion of sales and ~$520 million of EBITDA leave the company, and the overhead that supported them has to be removed for the stated margin uplift to be real. GAAP earnings remain thin relative to the market value, with trailing net income of ~$277 million against a ~$21.5 billion capitalization, because ~$948 million of annual depreciation and amortization and a string of disposal charges sit between EBITDA and reported profit. Goodwill of ~$8.1 billion and intangibles of ~$3.7 billion still make up a large share of a ~$14.0 billion equity base that already absorbed multi-billion-dollar impairments in 2022 and 2023, so further writedowns are possible if end markets soften. Antitrust exposure is also open: European Commission, UK CMA and Swiss inspections of fragrance pricing continue, and while IFF settled the U.S. civil class actions for roughly $43 million in provisions, an Israeli class action over a Frutarom-era bonus was certified in September 2025 with a rehearing motion still pending. SYIEY: The largest risk is growth falling short of plan. Organic growth of 2.8% in 2025 and 2.0% in H1 2026 sits well under the 5% to 7% medium-term target, and the stock's ~25 times multiple of 2025 adjusted EPS (€92.24 share price in October 2026 against €3.67) assumes the business returns to something closer to its historic pace. Pet Food is in price normalization after earlier increases, so revenue there can fall even when volumes hold. Raw materials are a second risk: Symrise buys citrus, vanilla, mint and other naturals plus petrochemical feedstocks, and sudden cost spikes can squeeze margins before price increases catch up. The H1 2026 report already cited higher logistics costs tied to the Middle East. Currency is a third: reported sales lost about €210 million in 2025 to FX and portfolio effects, and an investor holding SYIEY in dollars carries euro exposure on top of the company's own mix of dollar, emerging-market and euro revenue. Past acquisitions have produced write-downs, including ~€150 million on Swedencare and ~€148 million on terpenes in Q4 2025, so further M&A such as Floral Concept carries integration and valuation risk. The ONE SYM transformation spends money now for savings later, and it may take longer than planned. Competition from Givaudan, dsm-firmenich and IFF is intense, and large consumer-goods customers have significant purchasing power. Finally, SYIEY is an unsponsored ADR traded over the counter, so volume is thin, spreads can be wide, Citibank may deduct depositary fees from dividends, and German withholding tax of 26.375% applies before any treaty reclaim.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell IFF or SYIEY; figures are approximate and dated (as of October 2026). Verify current data before investing.